Have a personal or library account? Click to login
Future Biotechnology Cover

Future Biotechnology

The EuroBiotech Journal
Volume 3 (2019): Issue 2 (April 2019)
By: Munis Dundar,  Satya Prakash,  Ratnesh Lal and  Donald K. Martin  
Open Access
|Apr 2019

Figures & Tables

Figure 1

Overview of the human genome. Gene and gene-related sequences cover 37.5% of the human genome, while genome-wide repeats constitute 43.75%. The remaining 18.75% are intergenic regions.
Overview of the human genome. Gene and gene-related sequences cover 37.5% of the human genome, while genome-wide repeats constitute 43.75%. The remaining 18.75% are intergenic regions.

Figure 2

Examples of symbio-bots (A–D) that can be created in a bioinspired way (E). Each device is separated with a smart porous packaging that allows a duplex communication. Therapeutic cells (A and B) need a porous encapsulation that avoids an immune reaction and allows protection from both sides. They may be human cells, as MSC or specialized cells such as β-cell from Langherans islets (A), or other eukaryotic or prokaryotic cells (B). Panel C shows an IBFC linked to an electronic medical device. Panel D shows a generic device delivering a therapeutic molecule. Panel E: Existing symbiosis (i.e., microbiota or pregnancy) are a source of bio-inspiration to establish a duplex communication between the body and its implants. Regenerative medicine should embrace this concept of bioinspiration for a better design and integration of implants, especially for future symbio-bots. (reproduced with permission from Alcaraz et al (10)).
Examples of symbio-bots (A–D) that can be created in a bioinspired way (E). Each device is separated with a smart porous packaging that allows a duplex communication. Therapeutic cells (A and B) need a porous encapsulation that avoids an immune reaction and allows protection from both sides. They may be human cells, as MSC or specialized cells such as β-cell from Langherans islets (A), or other eukaryotic or prokaryotic cells (B). Panel C shows an IBFC linked to an electronic medical device. Panel D shows a generic device delivering a therapeutic molecule. Panel E: Existing symbiosis (i.e., microbiota or pregnancy) are a source of bio-inspiration to establish a duplex communication between the body and its implants. Regenerative medicine should embrace this concept of bioinspiration for a better design and integration of implants, especially for future symbio-bots. (reproduced with permission from Alcaraz et al (10)).
DOI: https://doi.org/10.2478/ebtj-2019-0006 | Journal eISSN: 2564-615X
Journal RSS Feed
Language: English
Page range: 53 - 56
Published on: Apr 24, 2019
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Medical biotechnology,
nanotechnology,
genetics,
future developments
Related subjects:
Life sciences,
Genetics,
Biotechnology,
Bioinformatics,
Life sciences, other

© 2019 Munis Dundar, Satya Prakash, Ratnesh Lal, Donald K. Martin, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 3 (2019): Issue 2 (April 2019)Next article